Jens Overgaard

Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy.

H. Thames, J. Overgaard, S. Bentzen, 1989, International journal of radiation biology.

Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury.

Bentzen, Overgaard, S. M. Bentzen, 1994, Seminars in radiation oncology.

Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.

S M Bentzen, J. Overgaard, S. Bentzen, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.

J. Overgaard, S. Bentzen, M. Overgaard, 1993, European journal of cancer.

Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix.

J. Overgaard, S. Bentzen, D. Pedersen, 1994, International journal of radiation oncology, biology, physics.

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation.

L. Bastholt, J. Overgaard, O. Hansen, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.

J. Overgaard, S. Bentzen, O. Hansen, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85.

J. Overgaard, H. Sand Hansen, M. Overgaard, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.